FEDERAL COURT OF AUSTRALIA
Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd (No 2)
[2019] FCA 657
File number(s): NSD 2149 of 2016 Judge(s): BURLEY J Date of judgment: 13 May 2019 Catchwords: COSTS – application for preliminary discovery pursuant to r 7.23 of the Federal Court Rules 2011 (Cth) – where prospective applicant was substantially successful in application which was contested by prospective respondents – discretion in making costs orders pursuant to s 43(2) of Federal Court of Australia Act1976 (Cth) to be exercised judicially – contingent costs order not appropriate – prospective applicant awarded 50% of its costs
PRACTICE AND PROCEDURE – preliminary discovery – confidentiality – principles to be applied – restrictions imposed
Legislation: Federal Court of Australia Act 1976 (Cth) s 37AF, 37M, 37N
Federal Court Rules 2011 (Cth) r 7.23
Patents Act 1990 (Cth) s 97(3)
Cases cited: C7 Pty Ltd v Foxtel Management Pty Ltd [2001] FCA 1864
Cappuccio v Australia & New Zealand Banking Group Ltd [1999] FCA 1188
Cobankara v Australia and New Zealand Banking Group Ltd [2017] FCA 419
Conor Medsystems Inc v University of British Columbia (No 4) [2007] FCA 324
Dallas Buyers Club LLC v iiNet Limited (No 3) [2015] FCA 422; 327 ALR 695
E D Oates Pty Ltd v Edgar Edmondson Imports [2012] FCA 356
Gearhart United Pty Ltd v Omni Oil Technologies (Asia) SDN BHD (No 2) [2010] FCA 558
Glencore International AG v Selwyn Mines Limited [2005] FCA 801; 223 ALR 238
Harman v Secretary of State for the Home Department [1983] 1 AC 280; 1 All ER 532
Hearne v Street [2008] HCA 36; 235 CLR 125
J & A Vaughan Super Pty Ltd v Becton Property Group Limited [2013] FCA 340
ObjectiVision Pty Ltd v Visionsearch Pty Ltd (No 3) [2015] FCA 304
Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCA 285
Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCAFC 193; 257 FCR 62
Procter v Kalivis (No 3) [2010] FCA 1194
Sabre Corporation Pty ltd v Russ Kalvin’s Hair Care Company [1993] FCA 841; 124 ALR 400
Date of hearing: 3 April 2019 Date of last submissions: 25 April 2019 Registry: New South Wales Division: General Division National Practice Area: Intellectual Property Sub-area: Patents and Associated Statutes Category: Catchwords Number of paragraphs: 32 Counsel for the Prospective Applicants: Mr D. Shavin QC with Mr C. Dimitriadis SC and Ms C. Cochrane Solicitor for the Prospective Applicants: DLA Piper Australia Counsel for the Prospective Respondent: Mr B. Caine QC with Mr J. S. Cooke and Mr D. B. Larish Solicitor for the Prospective Respondent: Ashurst Australia ORDERS
NSD 2149 of 2016 BETWEEN: PFIZER IRELAND PHARMACEUTICALS
First Prospective Applicant
WYETH LLC
Second Prospective Applicant
PFIZER AUSTRALIA PTY…
Keep reading for free
Create a free CaseChat account to read Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2019] FCA 657
- Decision Date
CaseChat Overview and Summary
The court was required to decide several legal issues, including the appropriate exercise of discretion in making costs orders under section 43(2) of the Federal Court of Australia Act 1976, and the principles to be applied when determining whether to impose restrictions on the disclosure of confidential information during preliminary discovery. The court also needed to consider whether a contingent costs order was appropriate given the substantial success of Pfizer Ireland Pharmaceuticals in the application, despite it being contested.
The court exercised its discretion judiciously, taking into account the substantial success of Pfizer Ireland Pharmaceuticals in the application, which was contested by Samsung Bioepis. The court determined that a contingent costs order was not appropriate and instead awarded Pfizer Ireland Pharmaceuticals 50% of its costs. The court emphasised the need for confidentiality in preliminary discovery proceedings and imposed restrictions on the disclosure of certain information to protect the interests of both parties. The court outlined a process for the submission of costs, allowing both parties to provide written submissions and potentially respond to each other, before deciding whether to proceed to a hearing.
The court's orders included a timeline for the submission of written costs submissions and a procedure for determining the costs of the application. If no party filed written submissions in accordance with the specified timeline, certain orders would be made, and the question of costs would be addressed in separate orders. The court's approach ensured a balanced consideration of the interests of both parties while maintaining the confidentiality required in such proceedings.
Orders
Orders of the court
1. If either party desires to make a separate submission as to costs of the 3 April 2019 application, they must file and serve a written submission of no more than 4 pages within 7 days of these orders.
2. The other party may respond by filing and serving a written submission of no longer than 4 pages within 7 days thereafter.
3. Any reply submission of no more than 2 pages to be filed within 7 days thereafter.
4. The application will then be determined on the papers unless either party indicates a desire for a hearing.
5. If no party files written submissions in accordance with Order 1, Orders in accordance with those set out in Annexure A (and accompanying Annexure 1) will be made and the words “including the costs of the application of 3 April 2019” will be added to Order 19. If additional costs submissions are made, Orders in accordance with Annexure A (and accompanying Annexure 1) will be made 7 days after these Orders, and the question of costs of the 3 April 2019 application will be addressed in separate Orders.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi